PMS2 Expression With Combination of PD-L1 and TILs for Predicting Survival of Esophageal Squamous Cell Carcinoma

BACKGROUND: DNA mismatch repair (MMR) deficiency (dMMR) has been recognized as an important biomarker for immunotherapy in esophageal squamous cell carcinoma (ESCC), along with programmed death ligand 1 (PD-L1) expression and/or tumor-infiltrated lymphocytes (TILs). However, in ESCC, MMR protein ass...

Descripción completa

Detalles Bibliográficos
Autores principales: Jiang, Dongxian, Song, Qi, Wei, Xiaojun, Yu, Zixiang, Liu, Yufeng, Wang, Haixing, Wang, Xingxing, Huang, Jie, Su, Jieakesu, Hong, Yang, Xu, Yifan, Xu, Chen, Hou, Yingyong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9294642/
https://www.ncbi.nlm.nih.gov/pubmed/35865481
http://dx.doi.org/10.3389/fonc.2022.897527

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9294642/
https://www.ncbi.nlm.nih.gov/pubmed/35865481
http://dx.doi.org/10.3389/fonc.2022.897527

Ejemplares similares